Causes of late diagnosis and treatment delay of breast, cervical cancers and childhood cancer of different localisations

Determinants of late diagnosis and delayed treatment cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN11442818

Enrollment

300

Registered

2022-02-07

Start date

2021-12-01

Completion date

Unknown

Last updated

2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast, cervical and childhood cancers Cancer Malignant neoplasm of breast, Malignant neoplasm of cervix uteri

Interventions

This is a prospective study that will include breast, cervical or childhood cancer patients recently diagnosed with all stages of the disease who are referred for treatment. It is envisaged that at

b) time/delay between the first consultation by the doctor and effective diagnosis, and, c) time between the diagnosis and beginning of treatment. The study questionnaire has been designed to explore

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have confirmed breast, cervical, or childhood cancer 2. Older than 18 years (for adult cancers) or younger than 21 years (for childhood cancers) 3. Histology report available and confirms precancer lesion or invasive malignant cancer 4. New presented cases, up to 3 months from the day of first medical visit at the center 5. Agreed with informed consent to participate in the project

Exclusion criteria

Exclusion criteria: 1. Cognitive or social disorder that impairs the ability to understand the interview 2. Ideally, a patient who is halfway through treatment should NOT be newly enrolled. An exception can be made in study sites with a low number of new cases or for low prevalent cancer types

Design outcomes

Primary

Measure	Time frame
Barriers of late diagnosis and delayed treatment of patients with breast, cervical, and childhood cancers by interviewing patients (parents/ guardians in cases of childhood cancer) in accordance with developed questionnaires. There are two interviews for each participant: the first - no later than 3 months after the first visit to the treatment center, the second - 6 months after the first interview.	—

Measure

Time frame

Barriers of late diagnosis and delayed treatment of patients with breast, cervical, and childhood cancers by interviewing patients (parents/ guardians in cases of childhood cancer) in accordance with developed questionnaires. There are two interviews for each participant: the first - no later than 3 months after the first visit to the treatment center, the second - 6 months after the first interview.

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Belarus, Moldova, Romania, Russian Federation

Contacts

Public ContactAlesia;Yuriy Evmenenko;Komarov

;

evmenenkoalesya88@gmail.com;md.komarov@gmail.com+375 (0)17 265 39 52;+7 (0)812 439 955 5

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026